Form 8-K - Current report:
SEC Accession No. 0001193125-21-198782
Filing Date
2021-06-24
Accepted
2021-06-24 17:01:19
Documents
12
Period of Report
2021-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d182784d8k.htm   iXBRL 8-K 32869
  Complete submission text file 0001193125-21-198782.txt   155365

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20210622.xsd EX-101.SCH 2904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20210622_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20210622_pre.xml EX-101.PRE 11416
5 EXTRACTED XBRL INSTANCE DOCUMENT d182784d8k_htm.xml XML 3413
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 211043593
SIC: 2834 Pharmaceutical Preparations